Status:
COMPLETED
Endoscopic Negative Pressure Therapy After Oncological Gastrectomies
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Anastomotic Leak Esophagus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Background and study aims: Management of esophago-jejunal anastomotic leackages (EJAL) after gastric resections is challenging. Endoscopic negative pressure therapy (ENPT) is an emerging effective too...
Detailed Description
Endoscopic negative pressure therapy (ENPT): OPD: The commercially available Eso-SPONGE® System (B. Braun Melsungen AG, Melsungen, Germany) was used for endoluminal vacuum therapy. For positioning th...
Eligibility Criteria
Inclusion
- anastomotic leak after oncological gastrectomy
Exclusion
- all other patients
Key Trial Info
Start Date :
January 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 20 2020
Estimated Enrollment :
8 Patients enrolled
Trial Details
Trial ID
NCT04362605
Start Date
January 1 2018
End Date
January 20 2020
Last Update
April 27 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Tuebingen
Tübingen, Germany, 72076